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Abstract: Anastomotic leakage (AL) is a common and dangerous post-operative complication fol-
lowing intestinal resection, causing substantial morbidity and mortality. Ischaemia in the tissue
surrounding the anastomosis is a major risk-factor for AL development. Continuous tissue oxygena-
tion monitoring during the post-operative recovery period would provide early and accurate early
identification of AL risk. We describe the construction and testing of a miniature implantable electro-
chemical oxygen sensor that addresses this need. It consisted of an array of platinum microelectrodes,
microfabricated on a silicon substrate, with a poly(2-hydroxyethyl methacrylate) hydrogel membrane
to protect the sensor surface. The sensor was encapsulated in a biocompatible package with a wired
connection to external instrumentation. It gave a sensitive and highly linear response to variations
in oxygen partial pressure in vitro, although over time its sensitivity was partially decreased by
protein biofouling. Using a pre-clinical in vivo pig model, acute intestinal ischaemia was robustly and
accurately detected by the sensor. Graded changes in tissue oxygenation were also measurable, with
relative differences detected more accurately than absolute differences. Finally, we demonstrated its
suitability for continuous monitoring of tissue oxygenation at a colorectal anastomosis over a period
of at least 45 h. This study provides evidence to support the development and use of implantable
electrochemical oxygen sensors for post-operative monitoring of anastomosis oxygenation.
Keywords: oxygen sensor; electrochemical; microfabricated; oxygenation; anastomotic leakage
1. Introduction
Creation of a surgical anastomosis (a connection between two hollow structures)
following intestinal resection is generally highly successful. However, if healing of the
anastomosis fails, luminal contents can leak into the abdomen causing septic peritonitis—a
dangerous and often lethal complication. Overall anastomotic leak (AL) rates are typically
6–7%, but can be as high as 24% for rectal operations [1,2]. Patients with an AL have
significantly increased mortality of up to 32% [3], and poorer oncological outcomes [4].
AL also has substantial associated economic costs, estimated at USD 28.6 M per thousand
patients [5]. Development of new technologies for monitoring anastomosis patients to
reduce the incidence of AL and improve clinical outcomes, are, therefore, a focus of
substantial clinical and engineering effort [6].
Insufficient tissue oxygenation is a key physiological factor influencing anastomotic
leakage. It leads to impaired wound-healing, necrosis (tissue death), and dehiscence
(separation of the joined tissue) [7,8]. Multiple clinical studies have shown that intra-
operative assessment of intestinal perfusion or oxygenation immediately after resection
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can be predictive of intestinal AL [6]. The techniques used in these studies include laser
fluorescence angiography with indocyanine green, and laser Doppler flowmetry for mea-
suring local blood flow [9,10]; near-infrared spectroscopy and visible light spectroscopy
for measuring tissue haemoglobin oxygen saturation (StO2) [11,12]; pulse oximetry for
arterial haemoglobin oxygen saturation (SpO2) [13]; and polarography using a Clark-type
electrode to directly measure the partial pressure of O2 in tissue (ptO2) [14]. These studies
have established the importance of tissue oxygenation in the aetiology of AL, and they
demonstrate the value of sensor technologies in assisting clinical decision making.
However, intra-operative techniques cannot fully predict the development of AL, and
many of the pathological processes associated with leakage occur post-operatively [7,8].
Suspected leaks are typically investigated using radiological imaging modalities such as
computerised tomography (CT) and contrast radiography, but these are limited by cost and
patient radiation exposure, and they introduce delays before AL treatment commences [6].
Continuous post-operative monitoring of local tissue oxygenation is, therefore, a highly
desirable alternative. It could provide a means to assess anastomotic healing easily and
rapidly, optimising patient treatment planning. For example, interventions to improve
oxygenation of the anastomosis may prevent a leak from occurring, while early leak
diagnosis may enable revision surgery to be performed before sepsis becomes established.
In principle, post-operative monitoring could be achieved using one or more implantable
oxygen sensors placed at the anastomotic site during surgery.
Commercial oxygen sensors are typically bulky and unsuitable for implantation, so
we previously developed a miniature electrochemical Clark-type tissue oxygen sensor
to address this need [15]. Electrochemical oxygen sensors operate by biasing a platinum
electrode at an oxygen reducing potential, with a resulting current that is proportional to
oxygen partial pressure. Our previous sensor was microfabricated on a silicon die, and
contained a platinum working electrode (WE) and counter electrode (CE), and an on-chip
Ag/AgCl reference electrode (RE). Its surface was protected with a thin ionomer membrane.
We showed that it was effective at detecting intestinal ischaemia and tissue hypoxia in a
rat model [16]. However, it suffered from a short lifetime due to failure of its RE, and was
susceptible to biofouling, causing a loss of sensitivity [15]. Here, we introduce an enhanced
version of the sensor that addresses these problems. We describe its bench characterisation
and the validation of its performance in a pig colorectal anastomosis model.
2. Materials and Methods
2.1. Electrode Fabrication
Devices were fabricated on 100 mm diameter N-type <100> silicon wafers (Si-Mat).
First, a silicon dioxide layer (thickness 500 nm) was grown on the wafer surface by thermal
oxidation to insulate the electrodes from the bulk silicon. The platinum electrode and inter-
connect layer (thickness 50 nm), with an underlying titanium adhesion layer (thickness
10 nm), were then deposited by electron beam evaporation, and patterned by a photolithog-
raphy and photoresist lift-off process. The aluminium bond pad layer (thickness 1000 nm)
was deposited next by sputtering, then patterned by a photolithography and photoresist
lift-off process. Finally, an upper passivation layer of silicon dioxide (thickness 500 nm)
was deposited by plasma-enhanced chemical vapour deposition, then patterned by pho-
tolithography and reactive ion etching using an O2/CF4 plasma to define and expose the
electrode and bond pad areas (Supplementary Figure S1). A temporary protective layer of
photoresist was deposited on the wafer to avoid corrosion and physical damage, followed
by dicing into individual 2 mm × 3 mm dies, each containing a single microelectrode array.
2.2. Assembly and Packaging
A custom 1.7 mm × 33.1 mm flexible polyimide printed circuit board (PCB) (Merlin
Flex Ltd., Hawarden, UK) was used for sensor assembly. The board was manufactured
from two layers: a bottom layer (25 µm polyimide and 25 µm adhesive) with a single
copper track (thickness 35 µm), and a top layer (also 25 µm polyimide and 25 µm adhesive)
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of coverlay. A stiffener (250 µm polyimide) was added to the bottom layer to improve
mechanical stability in the die mounting and soldered connection areas. Exposed copper
regions were created in the coverlay for wire bonding and soldering. All exposed copper
was ENIG (electroless nickel immersion gold)-coated. A 50 cm biocompatible PVC-coated
30 AWG copper wire lead (Alpha Wire, Elizabeth, NJ, USA) was soldered to the flex for
connectivity to external instrumentation.
The sensor die was stripped of its protective photoresist, then mounted on the flexible
circuit board using Loctite 4014 biocompatible adhesive (Loctite, Westlake, OH, USA).
Gold wire bonds between the flexible PCB track and die pad were produced by ultra-
sonic ball bonding. Encapsulation was then performed using EPO-TEK OG116-31 bio-
compatible UV-curable epoxy (Epoxy Technology Europe Ltd., Marlborough, UK) as
previously described [15]. In brief, epoxy was deposited on the whole assembly and
cured over the wire bonds and die edges by selective UV exposure through a glass pho-
tomask. Uncured epoxy was removed using acetone, producing a package of approximately
2.8 mm × 5.1 mm × 1.4 mm (W × L × H) with an open window over the electrodes of
approximately 1.4 mm × 1.8 mm (W × L). Epoxy was then manually applied to the back
of the sensor, its front and rear edges, and the soldered sensor lead connection, then cured
by flood UV exposure. The packaged sensor was baked at 80 ◦C for 2 h to ensure biocom-
patibility of the cured epoxy, then at 150 ◦C for 5 min (above the epoxy glass transition
temperature of 137 ◦C) to improve its hermeticity [17]. Sensors to be used for implantation
were sterilised by exposure to ethylene oxide (AN-73 EtO capsule, Andersen Products,
Clacton-On-Sea, UK) for 12 h at room temperature and pressure, then degassed in air for
>2 h, prior to hydrogel casting.
2.3. Hydrogel Casting
Preparation of the poly(2-hydroxyethyl methacrylate) (pHEMA) sensor coating was
based on a previously described protocol [18], and was performed under cleanroom
conditions. All reagents were obtained from Merck Life Science UK Ltd. (Gillingham, UK).
In brief, 2-hydroxyethyl methacrylate (HEMA) was pre-treated with inhibitor remover
beads (306312), then filtered to remove the beads. A hydrogel precursor mixture was made
containing (% w/w): 63% HEMA monomer, 1% ethylene glycol dimethacrylate crosslinker,
35% deionised water, and 1% 2-hydroxy-2-methylpropiophenone UV photo-initiator. The
mixture was stirred for 10 min in darkness, then filtered. Each sensor cavity was filled with
1.5 µL of the mixture (giving a hydrogel depth of approximately 0.6 mm), then exposed to
UV light for 5 min to polymerise the poly-HEMA (pHEMA) hydrogel. Finally, sensors were
transferred to a large volume of sterile phosphate buffered saline (PBS), with a composition
of 154 mM NaCl and 10 mM phosphate buffer at pH 7.4, for at least 1 day prior to use.
This provided time to allow unreacted precursors to diffuse out of the hydrogel, and to
equilibrate it with the saline electrolyte.
2.4. Electrochemistry
Bench characterisation was performed using an Autolab PGSTAT12 potentiostat
equipped with a MUX.MULTI4 multiplexer (Metrohm AG, Herisau, Switzerland) and con-
trolled by NOVA 1 software. Cyclic voltammetry (CV) was performed with a sweep rate of
100 mV/s and a step size of 2 mV. Chronoamperometry (CA) was performed for 20 s with
a 100 ms sample interval. A double-junction Ag/AgCl electrode (Merck Life Science UK
Ltd.) with a saturated KCl outer filling solution was used as a combined counter/reference
electrode for all in vitro measurements. PBS was used as an electrolyte for sensor char-
acterisation. Oxygen sensitivity was measured in solutions degassed using argon until
the required oxygen partial pressure was achieved. Oxygen partial pressure in solution
was measured using a Seven2Go S9 meter with an InLab OptiOx probe (Mettler Toledo,
Leicester, UK). Oxygen response speed was assessed in the same degassing apparatus,
using repeated measurements with an interval of 2 min. Susceptibility to biofouling was
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assessed in 35 mg/mL bovine serum albumin (Merck Life Science UK Ltd.) in air-saturated
PBS, using repeated measurements with an interval of 60 min.
In vivo recordings and pre/post-implantation sensor testing were performed using
an EmStat3 Blue portable potentiostat equipped with a MUX8-R2 multiplexer (PalmSens
BV, Houten, The Netherlands) and controlled by PSTrace 5.4 software. The potentiostat
was powered by a 10.8 Ah USB powerpack, and connected via Bluetooth to minimise
pickup of electrical noise from the control computer. CA was performed for 20 s with
a 100 ms sample interval, as used for bench characterisation. Measurements were re-
peated at intervals of 2 min. A BlueSensor P P-00-S electrocardiogram Ag/AgCl electrode
(Ambu Ltd, Alconbury Weald, UK) placed on the abdomen skin was used as a combined
counter/reference electrode for all in vivo measurements. Pre/post-implantation sensor
testing was performed in sterile PBS using a double-junction Ag/AgCl electrode as a
combined counter/reference electrode.
2.5. Animals
In vivo studies were carried out under a UK Home Office Project Licence in accordance
with the Animals (Scientific Procedures) Act 1986. Approval to conduct these studies was
obtained from the University of Edinburgh Animal Welfare and Ethical Review Boards.
Three juvenile (2–3 months of age) female Landrace cross commercial breed pigs, each
weighing 30–45 kg, were transported from the farm of origin and used immediately.
2.6. General Anaesthesia
Specialist veterinary anaesthetists or veterinary surgeons registered in a specialist
training programme managed all aspects of anaesthesia. Details of all drug doses and
manufacturers are provided within Supplementary Table S1. All pigs received intramus-
cular pre-anaesthetic medication consisting of morphine, medetomidine, alfaxalone and
midazolam. Once adequate sedation was apparent, general anaesthesia was induced with
isoflurane (1–3%) delivered in 100% O2 via a mask. All pigs underwent tracheal intubation
with an endotracheal tube (ET). Two pigs required intravenous alfaxalone to facilitate
intubation. Following inflation of the ET cuff, general anaesthesia was maintained with
isoflurane, vaporised in an O2/air mixture (FiO2 0.45–0.55) in combination with partial
intravenous anaesthesia (alfaxalone, morphine, medetomidine and midazolam) given as a
continuous rate infusion. Inhaled gases were provided through a Lack or circle breathing
system connected to the ET with end-tidal isoflurane concentrations of 1.5–2.0% used to
maintain unresponsiveness. Mechanical lung ventilation was provided to achieve a tidal
volume of 8–10 mL/kg. Instrumentation consisted of surgical placement of a 7 Fr jugular
venous catheter and a 3 Fr carotid arterial catheter. Intravenous fluids were provided
through the jugular catheter to replace lost fluids/electrolytes, sustain cardiac preload
and help maintain mean arterial blood pressure in the range of 70–80 mmHg. Arterial
blood samples, taken from the carotid cannula, were used for intermittent biochemical,
haematological and blood-gas analysis using a portable blood gas electrolyte and critical
care analyser (epoc, Woodley Equipment Company Ltd, Bolton, UK). A multiparameter
monitoring device (Datex-Ohmeda S/5, SOMA Technology, Bloomfield, CT, USA) was used
to assess electrical activity of the heart, pulse rate and blood pressure, in combination with
pulse oximetry, capnography, spirometry and inspired/expired gases (inhaled anaesthetic
agent, CO2 and O2). Core body temperature was monitored using rectal and oesophageal
thermistors and maintained in the range of 38.5–39.5 ◦C. Pre-emptive analgesia was pro-
vided at the time of pre-anaesthetic medication. All pigs received intravenous cefuroxime
every 8 h. One pig required a single intravenous injection of neutral insulin (0.5 IU/kg),
a constant rate infusion of glucose (60–500 mg/kg/h) and a single intravenous injection
of frusemide (1 mg/kg) to correct hyperkalaemia, maintain normoglycemia and maintain
urine output, respectively.
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2.7. Surgery
Two surgical groups were used, consisting of either jejunal artery ligation in com-
bination with FiO2 alterations, or colorectal anastomosis. The pig undergoing colorectal
anastomosis received a warm water rectal enema immediately after anaesthesia induction.
All animals underwent a ventral midline celiotomy. A 12 Fr Foley catheter was also placed
in the bladder and connected to a closed urinary collection system. All animals were
euthanised with intravenous sodium pentobarbitone following completion of the protocol.
Post-mortem examination was performed to assess the extent of ischaemic pathology, as-
sess anastomotic integrity, and recover the sensors for post-implantation analysis. Intestinal
samples were also obtained for histopathology.
2.7.1. Jejunal Artery Ligation
A 50 cm section of jejunum was exteriorised. Two sensors were placed in the centre
of a 20 cm section of jejunum that was later rendered ischaemic, and two were placed on
a control proximal segment of jejunum with a normal vascular supply. All sensors were
placed on the antimesenteric border of the intestine and sutured in place with 2 M PDS
II (polydioxanone, Ethicon, Raritan, NJ, USA). Sensors were kept moist and placed at the
midpoint between small serosal blood vessels. Sensor leads were exteriorised through the
body wall and connected to external instrumentation. Jejunal arteries supplying the 20 cm
section of jejunum encompassing the test area were individually ligated with 2 M PDS II
(polydioxanone, Ethicon) and sectioned to create a localised area of ischaemia. The ventral
midline celiotomy was closed routinely; 3 M PDS II (polydioxanone, Ethicon) was used for
linea alba and subcutaneous tissue layer closure and 3 M Prolene (Polypropylene, Ethicon)
was used for skin closure.
2.7.2. Colorectal Anastomosis
A circular double stapled colorectal resection and anastomosis was performed as
previously described in detail [19]. Briefly, the colon and anterior rectum were mobilised
and isolated with laparotomy pads at the site of the proposed resection and anastomosis,
approximately 7 cm from the anus. At this location, the vasa recta of the inferior mesenteric
artery and vein were ligated with 2 M PDS II (polydioxanone, Ethicon) and divided. A
linear stapling device was placed across the upper rectum, sealing the distal end. The
proximal end was transected with a scalpel and a further 5 cm of proximal colon was
resected. The proximal part of anastomosis was first prepared by use of a purse-string
clamp with 2 M Prolene (Polypropylene, Ethicon) on a straight needle. The anvil component
of a 25 mm curved intraluminal stapling device (Endo-Surgery ILS 25, Ethicon) was placed
in the intestinal lumen and the Prolene (Polypropylene, Ethicon) suture tightened around
it. The handle portion of the stapling device was introduced per rectum towards the rectal
transverse staple line. Once in position, the stapling device was opened to advance the
point through the intestinal wall adjacent to the staple line. The anvil within the proximal
intestine was then connected to the pointed portion of the stapling device within the rectum.
With the colon and rectum held in proper alignment, the instrument was closed to compress
the tissues upon which the staples were fired to form the anastomosis. The instrument was
withdrawn from the rectum, and the head assembly was removed to check for intestinal
donut completeness. An air leak test was then performed to verify anastomotic integrity.
Four sensors were placed, two on each side of the anastomotic site on the antimesenteric
border of the colon and anterior surface of the rectum and sutured in place with 2 M PDS
II (polydioxanone, Ethicon). Sensors were kept moist and placed at the midpoint between
small serosal blood vessels. No tension was noted on the colorectal anastomosis when
lying in its normal anatomical position. As previously described, the sensor leads were
exteriorised through the body wall and the ventral midline celiotomy was closed routinely.
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2.8. Computed Tomography Imaging
A single-section SOMATOM Definition AS 64-slice helical CT system (Siemens Health-
care Ltd., Camberley, UK) was used to obtain contrast CT images of the descending colon
and rectum. The imaging parameters of the scanner were 120 kVp, 35 mA, 3–5 mm col-
limation with 1 mm section thickness. All scans were performed to include the entire
abdominal cavity. Positive contrast barium CT scans were performed immediately after
euthanasia in the pig which underwent anastomotic surgery. To perform the contrast
study, a rectal balloon catheter was positioned within the anus and the balloon inflated.
Approximately 150 mL of Gastrografin (meglumine amidotrizoate, Bayer, Reading, UK)
diluted 1:3 with water was injected through the catheter into the rectum and colon. CT
scans were performed immediately after instillation of the contrast agent. Integrity of the
anastomosis was evaluated through assessment of the staple line and leakage of contrast
material outside the intestinal lumen.
2.9. Histopathology
Intestinal tissue samples across ischaemic and anastomotic sites from pigs in both
protocols underwent ‘Swiss rolling’ and were fixed for at least 24 h (depending on tissue
thickness) in 4% formaldehyde (Genta Medical, York, UK). Tissues underwent processing
and paraffin embedding before sections were cut for haematoxylin and eosin staining as
previously described [20].
2.10. Statistical Methods
Long-term recordings were analysed using MATLAB R2020b (MathWorks, Natick,
MA, USA) to produce a time-series of steady-state current (the mean of the last 15–20 s) in
each CA recording. Microsoft Excel was used for all additional data handling. Statistical
analysis was performed with Prism 8 (GraphPad Software, San Diego, CA, USA). Linear
regression was used to calculate oxygen sensitivity and drift. A repeated measures one-
way ANOVA followed by a Bonferroni post-hoc test was used to test for differences
among multiple groups with a single factor (FiO2 absolute differences analysis), and a
repeated measures two-way ANOVA followed by Bonferroni post-hoc testing was used to
test for differences between multiple groups with two factors (ischaemia and biofouling
analyses). A one-sample t-test was used to test for deviation from a hypothetical value of
zero (FiO2 relative differences analysis). Normality of all datasets was confirmed using a
Shapiro–Wilk test prior to parametric analysis. All data in text and figures are presented as
mean ± standard error of the mean.
3. Sensor Design
The sensor die (2.0 mm × 3.0 mm) was microfabricated on a silicon wafer substrate,
and it consisted of a 3 × 3 array of circular platinum microelectrodes (50 µm electrode
diameter, 200 µm pitch) placed at the centre of the die (Figure 1a). This array design
was preferred over a single electrode to provide an increased WE current, while retaining
favourable microelectrode properties, including a small diffusion layer and a steady state
during chronoamperometric (CA) measurements. Since temporary post-operative monitor-
ing applications allow the use of a wired sensor, an external off-chip Ag/AgCl electrode
was used as a combined reference/counter electrode (RE/CE). The platinum WE metal
layer extended under the whole array, with individual active electrode areas defined by
windows in an upper passivation layer. Platinum was also used for an interconnect track
(width 200 µm) between the electrode array and an aluminium bond pad at the edge of
the die (Figure 1b). An overlap of 10 µm was used at the pad periphery to create a robust
electrical connection between the interconnect and bond pad.
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Photograph of a fully packaged sensor, flexible PCB, and connection lead. (d): Schematic cross-section of the sensor epoxy
packaging and pHEMA hydrogel membrane (not to scale). Reproduced with permission from [15].
The electrode die was mounted on a flexible PCB and wire bonded to a gold-coated
track on the PCB. An insulated lead was also attached to the track for connection to external
potentiostat instrumentation. To allow accurate surgical placement, notches were included
on the flexible PCB to enable it to be sutured securely onto tissue (Figure 1c). The sensor
and its connections were encapsulated selectively in biocompatible photocurable epoxy to
provide insulation and mechanical stability. A small window in the epoxy was left open
over the die, creating a shallow cavity into which a thick (~600 µm) pHEMA hydrogel
layer was cast (Figure 1d). This hydrogel was used to explore the effectiveness of a thick
membrane for mitigating the effects of biofouling. The aim was to displace the critical
tissue/sensor interface away from the WE (providing a large non-fouled internal volume of
hydrogel in which to make transient oxygen measurements), and to create a large surface
area through which oxygen could diffuse from tissue into the sensor (reducing the effect of
biofouling on oxygen mass transport).
4. Results
4.1. Sensor Characterisation
To confirm the ability of the sensor to electrochemically detect oxygen, it was immersed
in PBS and subjected to cyclic voltammetry. The expected oxyg n wave was present at
reducing potentials in air-saturated PBS, nd it was lost following removal of oxygen
from the solution by sparging with a gon (Figure 2a). This showed that the sensor was
effective at reducing oxygen t its WE surface. To quantify the oxygen re uction current,
we elected chronoamper metry (CA) at a redu ing potential of −0.5 V (vs. Ag/AgCl),
as previou ly reported [15]. The sensor output was quantified as an average current
over 15–20 s following the potential step, since a steady-state was well established by this
timepoint (Supplementary Figure S2).
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Figure 2. Bench characterisation of sensor performance. (a): Typical CV scans of sensor in PBS saturated with air (red) and
PBS degassed by sparging with argon (blue). Similar results were obtained from four sensors. (b): Mean steady-state WE
current at −0.5 V measured over a range of oxygen partial pressures in PBS (n = 3 sensors). (c): Sensor response when
e at t 0 i fr ar -s ar e ( e li i le e ) t a air-sat rate s l ti . tea -state c rre ts
t i i se ti e. Individual responses from four sensors are shown (red lines). (d): Mean steady-state current at
−0.5 V in air-saturated PBS over 24 h. Sensor recordings were performed at intervals of either 2 min (red) or 60 min (blue)
(n = 3 sensors/condition).
s siti it s s r i t r f rti l r ss r l s
t . kPa and 21.2 kPa (air at tmospheric pressure). The CA steady-state current was
recorded at each p rtial pressure after allowing the sensor to equilibrate for ≥1 h. A highly
linear respons (R2 > 0.99) was observed, with a sensitivity of −0.600 ± 0. 06 nA/kPa and
offset of −0.019 ± 0.076 nA (Figure 2b). Sensor response sp ed to a step-change i pO2
was measured by making rep at d CA measurements following transfer of t
l t )
r t t lis t t li )
t9 (ti e t
fi 7 min (n = 4 sensors).
t t t ilit s ss i r te s re ents i air-
s t r t , t s r t intervals of either 2 min or 60 min (Figure 2d). Over a 24 h
period, sensors measured at 2 min intervals showed a mean drift of −0.343 ± 0.070 nA/h,
while sensors measured at 60 min intervals showed a mean drift of −0.017 ± 0.008 nA/h.
Since the oxygen reduction current was also negative, these negative drift values indicated
a slowly increasing current over time. After 24 h, the coefficient of variance (CoV) between
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sensor outputs was 14.1% (2 min interval) and 1.8% (60 min interval). Together, this
indicates that the sensor output is more stable when longer intervals are used between
successive measurements.
4.2. In Vivo Performance
Performance of the sensor in vivo was assessed using an anaesthetised pig model.
There is substantial similarity in size and anatomy between the human and porcine gas-
trointestinal system [19], making it a highly relevant translational model for preclinical
validation of implantable sensors. Two study designs were used: the first to test perfor-
mance of the sensor, the second to investigate its suitability for intestinal anastomosis
monitoring. For in vivo testing, an Ag/AgCl electrocardiogram (ECG) electrode attached
to the skin was used as a combined RE/CE. ECG electrodes are specified by standard
ANSI/AAMI EC12:2000 to maintain a stable electrochemical potential even while passing
small continuous DC test currents (≥200 nA, for ≥8 h) or after a rapid charge transfer
(≥2 mC) during defibrillation. They were, therefore, expected to also be sufficiently stable
for use as a combined RE/CE in these low-current amperometric measurements.
In the first study (pigs A1 and A2), four sensors were implanted on the small intestine
to test their ability to detect ischaemia and tissue hypoxia. Of these, two sensors were
implanted on a control site, and two sensors on a test site that was later rendered ischaemic.
The sensors were anchored on the serosal (outer) surface using sutures over the flexible PCB
notches (Figure 3a(i)), and the abdomen was closed during recordings. Later post-mortem
inspection showed that the sutures provided reliable fixation. A further sensor was left free
in the peritoneal cavity with the intention of measuring oxygenation of the free peritoneal
fluid. Using this model, we first investigated detection of ischaemia. Initially, sensors
on both the (pre-ischaemic) test and control sites showed similar outputs, as expected
(Figure 3b). The test site was then rendered ischaemic by ligation of the jejunal artery
branches and division of the intestine from the mesentery (Figure 3a(ii)). Following this
surgery, the sensor output at the test site showed a pronounced and highly significant
decrease to near-zero output, indicating clear detection of ischaemia (Figure 3b). The
control site (non-operated) showed no significant change between the two measurement
periods. Presence of local ischaemia at the test site was confirmed by post-mortem histo-
logical analysis, which showed loss of enterocytes and villi and haemorrhage within the
submucosal layer (Supplementary Figure S3).
Using the same pigs, we then manipulated the fraction of inspired oxygen (FiO2) to
investigate whether more subtle changes in tissue oxygenation could be detected. First,
a baseline recording was made at an FiO2 of 0.50 (50% oxygen). Delivery of oxygen was
then sequentially increased to give an FiO2 of 1.00, returned to 0.50, then reduced to 0.21,
before finally returning to 0.50 (Figure 3c(i)). Effectiveness of these FiO2 interventions was
confirmed by changes in central arterial blood pO2 (Supplementary Figure S4). Continuous
sensor recordings were made throughout (Supplementary Figure S5). Analysis of the
absolute sensor output at each FiO2 from control (non-ischaemic) sites showed that, when
compared to baseline, weak trends were observed towards a higher output at FiO2 1.00
and a lower output at FiO2 0.21 (Figure 3c(ii)). These differences did not reach significance,
as the sample size was small and there was variability between individual sensor sites. We
also examined the relative differences in output from individual sensors between each FiO2
block. This analysis did show significant changes, appropriately positive and negative, at
every FiO2 step (Figure 3c(iii)). Together these comparisons suggest that quantification
of relative differences is likely to be more reliable than use of absolute values for patient
monitoring. As expected, sensors at the ischaemic test site gave consistently very low
readings throughout (Supplementary Figure S6a), while the free peritoneal sensor gave
readings that mirrored those of the intestinal control site (Supplementary Figure S6b).
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For the s cond study (pig A3), we investigated suitability of the s ns r for long-term
monitoring of tissue adjacent to a colorectal anastomosis. A sh rt section of colon was
resected, then re-joined using a stapled anastomosis cr ated with a circular staple gu
(Figure 4a). Two sensors were placed proximal to the anastomosis, and two sensors distal
to it. The sensors were fixed on the tissue using sutures, which was also found to provide
sufficient security at this site. As before, an additional sensor was left free in the abdomen
to measure peritoneal fluid. Sensor recordings were made continuously to monitor tissue
oxygenation over 45 h. Since long-term trends are often the most informative for high
dependency unit and intensive care monitoring, we averaged the sensor output over 5 h
intervals. All sensors gave outputs consistent with non-ischaemic tissue, indicating good
perfusion of the anastomosis (Figure 4b). No clear trends indicating the presence of tissue
hypoxia were observed at either the proximal or distal sensor sites during the 45 h post-
operative recording period, suggesting that the anastomosis remained well perfused by
oxygenated blood throughout. This was corroborated by post-mortem positive contrast CT,
which showed the anastomosis had not developed a leak (Figure 4c), and by histological
examination which showed healthy tissue both proximal and distal to the anastomosis
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(Supplementary Figure S7). All sensors were still functioning at the end of the experiment,
showing an in vivo sensor lifetime of at least 45 h. The experiment was terminated after
45 h as it was an initial proof-of-concept trial in an anaesthetised animal, and future work
will explore longer monitoring periods in animals recovered from anaesthesia.
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Figure 4. Continuous colorectal anastomosis monitoring. (a): Intra-operative photographs showing creation of a stapled
colorectal anastomosis and sensor placement. (i) Proximal colon with stapler anvil secured by a purse-string suture; (ii)
distal colon with transverse staple line and stapler spike protruding at the midpoint; (iii) proximal and distal colon joined
by closure and firing of the stapler; (iv) placement of distal sensors (gr en a rows) at the anastomosis (white a row). (b):
Mean steady-state cu rent from each sensor during the 45 h experiment, averaged over 5 h periods (five sensors, from one
pig). (c): Post-mortem positive contrast CT images taken following a colorectal resection and anastomosis. (i) Transverse
view. The positive contrast agent (Gastrografin) can be seen filling the rectum and distal colon. The contrast agent ran past
the anastomotic site with no evidence of leakage of contrast material outside the intestinal lumen. (ii) Sagittal view. This
image was taken through the anastomotic site. Three sensors can be identified surrounding the colon (green arrows). There
is no evidence of leakage of contrast material outside the intestinal lumen.
4.3. Assessment of Biofouling
To investigate the effect of biofouling on the O2 sensor in vitro, we used bovine
serum albumin (BSA), a protein commonly used to model biofouling and one of the main
components of peritoneal fluid [21]. Sensors were incubated in either PBS containing
BSA, or PBS alone as a control, and the steady-state current output in these air-saturated
solutions was measured over 48 h. A progressive and significant decline in output current
was observed from sensors incubated with BSA, when compared to the control sensors
in PBS (Figure 5a). This indicates that the sensor is susceptible to loss of sensitivity
due to protein biofouling in vitro. We also assessed the in vivo impact of biofouling by
comparing the sensor current output in air-saturated PBS before implantation and after
explantation at post-mortem. A significant decrease in the sensor current was observed
between the pre- and post-implantation outputs from sensors used in all in vivo studies
(Figure 5b), confirming that biofouling during implantation also led to a partial loss of
oxygen sensitivity.
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5. Discussion
We demonstrated an implantable electrochemical oxygen sensor that monitors post-
operative tissue oxygenation. Its key components were a platinum microelectrode array and
a pHEMA membrane to mitigate the impact of biofouling. The sensor was microfabricated
on a silicon substrate, allowing future integration with smart on-chip electronics to reduce
dependence on external instrumentation. An external Ag/AgCl ECG electrode was used
as a combined CE/RE. The miniature sensor was encapsulated in a biocompatible package
to allow surgical implantation and continuous monitoring of tissue oxygenation.
We showed that the sensor had a highly linear response to oxygen in vitro. The use of
a microelectrode array design increased (relative to a single electrode) the overall current
output to compensate for the lower diffusion coefficient of oxygen in pHEMA (typically
1 × 10−6 cm2s−1 [22]) compared to water (typically 2 × 10−5 cm2s−1 [23]). Overall, this
resulted in a similar oxygen sensitivity to our previous sensor design [15]. The lower
diffusion coefficient also led to a relatively slow response time of approximately 37 min.
This is unlikely to be a limitation in clinical use, as the physiological processes associated
with anastomotic ischaemia and leakage take place over several hours or days [7,8]. During
in vitro testing, we also identified an unexpected dependence of sensor output stability on
the inter-measurement interval, with more frequent measurements leading to decreased
stability. This may be due to reactive intermediates in the oxygen reduction reaction at
the WE affecting the pHEMA polymer properties [24], but further work will be required
to identify the cause conclusively. Since long-term trends in anastomosis oxygenation are
most clinically relevant, measure ent frequency can be minimised to ameliorate this effect.
Biofouling of implanted sensor membranes due to non-specific protein adsorption
is a well-known phenomenon, causing loss of sensitivity by disrupting the diffusion of
analytes [25]. Our use of a thick pHEMA membrane aimed to mitigate this effect by
physically spacing the electrode sufficiently far from the biofouled interface to prevent
it from affecting the output during a short measurement. For example, at the end of a
20 s recording, the diffusion length (approximated by
√
2Dt) would be expected to reach
approximately 63 µm from the electrode surface. This remains well within the ~600 µm
thick pHEMA hydrogel, never reaching or being affected by the outer biofouled layer.
Oxygen removed from the hydrogel by reduction at the WE was then replenished slowly
by diffusion through the biofouled interface during the interval between measurements.
Using incubation with BSA as an in vitro protein biofouling model, we found that the
pHEMA membrane allowed the sensor to retain 79% of its sensitivity after 24 h. In contrast,
our previous O2 sensor with a thin (0.5 µm) Nafion polymer membrane, analysed using the
same BSA assay, retained only 17% of its sensitivity after 24 h [15]. This is consistent with
our expectation of a correlation between membrane thickness and biofouling susceptibility.
Nevertheless, the thick pHEMA membrane was still affected by both BSA and the in vivo
Micromachines 2021, 12, 810 13 of 15
environment. This may be due to slow infiltration of proteins or smaller peptides into the
pHEMA hydrogel network, or passivation of the WE surface [25]. This will be the main
target for future improvement.
Sensor lifetime was ~23 h in our previous study [15], limited by failure of the on-
chip thin-film Ag/AgCl RE (originally designed for wireless applications [26]). In this
study, sensor lifetime was substantially improved to at least 45 h by use of an external
Ag/AgCl ECG electrode. This provides confidence that the sensor will, with further
refinement, be suitable for post-operative monitoring over several days during patient
recovery [6]. Clearly, such an external electrode is only viable for wired sensors, but where
a wired approach is possible it will eliminate the limitations of microfabricated reference
electrodes [27]. The present study also validates use of an Ag/AgCl ECG electrode for
low-current amperometric measurements, establishing it as a valuable experimental tool
for early testing of research sensors. It may be less suitable for sensitive potentiometric
measurements where millivolt differences in RE potential are significant, as the ECG
electrode internal electrolyte composition is not perfectly fixed.
We developed an in vivo pig model to test the sensor, informed by our previous work
in rat intestine [16]. Using this new model, we showed that the sensor was highly effec-
tive for detection of intestinal ischaemia created by arterial ligation. It was also partially
effective for detecting smaller differences in tissue oxygenation caused by experimentally
induced hypoxaemia and hyperoxaemia. Variability between sensors meant that relative
changes in oxygenation were detected more reliably than absolute differences. This may
be due to anatomical differences in sensor location, for example proximity to larger blood
vessels, causing the output from each to reflect its unique tissue microenvironment. We
also successfully demonstrated continuous monitoring of tissue oxygenation at a colorectal
anastomosis. These proof-of-concept studies show that electrochemical detection of intesti-
nal tissue oxygenation using this sensor architecture is suitable for translation into clinical
practice. The electrochemical measurement gives an output that is directly proportional to
oxygen partial pressure. Therefore, it compares favourably to near-infrared spectroscopy
and visible light spectroscopy, which use StO2 as a non-linear proxy for oxygenation, and
to pulse oximetry and laser Doppler flowmetry which require pulsatile blood flow [28].
Our future work will focus on improving the resistance of the sensor to biofouling,
enabling more accurate long-term measurements to be conducted. This platform also
offers the opportunity for further integration with other sensors. For example, previous
studies have shown that post-operative monitoring of multiple physiological parameters
downstream of ischaemia hold promise for predicting AL. These include pH [29] and
lactate [30], as well as inflammatory markers such as C-reactive protein [31]. Ultimately,
clinical translation of implantable oxygen sensor technology will enable monitoring for
threshold values of oxygen that presage leakage, allowing timely and evidence-driven
intervention. We believe that such continuous post-operative monitoring of anastomosis
healing will hold a key to improving the morbidity and mortality associated with AL.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/mi12070810/s1, Figure S1: electrode array microfabrication process, Figure S2: chronoam-
perometry recording in PBS, Figure S3: histological appearance of normal and ischaemic jejunal
segments, Figure S4: effectiveness of FiO2 alterations, Figure S5: real-time sensor output, Figure S6:
FiO2 challenges at ischaemic and peritoneal sites, Figure S7: histological appearance of colorectal
anastomosis site, Table S1: drugs used to provide anaesthesia and analgesia.
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